Search results

Two World Council of Churches (WCC) HIV initiatives met to review and celebrate the critical and life-changing work of the initiatives and to continue planning for a strengthened WCC HIV response in the new WCC Commission of the Churches on Health and Healing.

As a United Nations high-level meeting convenes from 8-10 June in New York, the World Council of Churches (WCC) is joining the UN and other faith-based and civic groups to review progress on commitments to end the AIDS epidemic by 2030.

A 13 Million Campaign is underway to engage faith leaders, individuals and communities in promoting access to health services for the 13 million children, women and men living with HIV who are not yet on antiretroviral treatment.

For World AIDS Day 2019, the World Council of Churches (WCC) embraces the theme "Communities make the difference." World AIDS Day is being commemorated in the context of 16 Days Against Gender-based Violence, an annual international campaign that began on 25 November and ends on 10 December, Human Rights Day. The WCC also helps bring about grassroots awareness and change through the Thursdays in Black campaign for a world free from rape and violence.

A publication entitled “When Food Becomes Immaterial: Confronting the Digital Age” is now available to help people explore the impact of technologies on what and how we eat, as well as on how food is produced.

The WCC is mourning the death of Calle Almedal, a great friend of WCC and of all faith communities, as well as a pioneer in the field of HIV. Almedal passed away on 7 June.

The WCC-EAA is inviting a “letter writing action”, encouraging religious leaders and faith communities to speak out for action against Tuberculosis (TB).

“What do we have the right to manipulate in creation?” The question is at the heart of a Canadian Quaker’s commitment to the process of encouraging member churches of the World Council of Churches (WCC) to reflect on scientific experiments in modifying life forms known as “synthetic biology”.

The World Council of Churches - Ecumenical Advocacy Alliance endorses a newly expanded collaboration on HIV between the Medicine Patent Pool and Gilead. On 4 October, the MPP announced a licence with Gilead Sciences for bictegravir, a new integrase inhibitor part of a once-daily, single-tablet HIV regimen currently filed for regulatory approval at the United States Food and Drug Administration and the European Union.

Policymakers, programme managers, and service providers — including faith communities — must use more human rights norms and standards to guide a global response to HIV, said a statement submitted by the Ecumenical Advocacy Alliance, an ecumenical initiative of the WCC, to the Human Rights Council on 11 March in Geneva.

At the 42nd Committee on World Food Security in Rome on 12-15 October, the intergovernmental body continued its quest to coordinate a global approach to food security.